Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas

Acta Radiologica

Volumn 53, Issue 1, 2012, Pages 95-101

  Thomsen, H ^a,b   Steffensen, E ^c   Larsson, E M ^c,d  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY COLLEGE OF NORTHERN DENMARK   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain brain stem structures; MR diffusion perfusion; MR imaging modalities techniques; Tissue characterization topics

Indexed keywords

ARTERIAL SPIN; BLOOD FLOW; BLOOD VOLUMES; BRAIN TUMORS; CEREBRAL BLOOD FLOW; CEREBRAL BLOOD VOLUME; CEREBRAL GLIOMAS; CLINICAL EVALUATION; CORRELATION COEFFICIENT; DSC MRI; DYNAMIC SUSCEPTIBILITY CONTRAST; GLIOBLASTOMAS; HISTOGRAM ANALYSIS; HUMAN BRAIN TUMORS; MEDIAN VALUE; MR IMAGING; MR-DIFFUSION/PERFUSION; PEAK HEIGHT; PEAK POSITION; PERFUSION MRI; REGIONS OF INTEREST; STATISTICAL COMPARISONS; STATISTICALLY SIGNIFICANT DIFFERENCE; TISSUE CHARACTERIZATION - TOPICS; TUMOR GRADES; WHITE MATTER;

BLOOD; BRAIN; GRAPHIC METHODS; HEMODYNAMICS; MAGNETIC SUSCEPTIBILITY; MEASUREMENTS; STATISTICAL METHODS; TUMORS;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOBUTROL; ORGANOMETALLIC COMPOUND;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD VOLUME; BRAIN CIRCULATION; BRAIN TUMOR; FEMALE; GLIOMA; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; VASCULARIZATION;

ADULT; ANALYSIS OF VARIANCE; BLOOD VOLUME; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; GLIOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES;

EID: 84856540513     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.110242     Document Type: Article

References (29)

1. Lacerda S, Law M. Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am 2009;19:527-57
2. Di Costanzo A, Pollice S, Trojsi F, et al. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Radiol Med (Torino) 2008;113:134-43 (Pubitemid 351387215)
3. Rollin N, Guyotat J, Streichenberger N, et al. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 2006;48:150-9 (Pubitemid 43380227)
4. Hakyemez B, Erdogan C, Bolca N, et al. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 2006;24:817-24 (Pubitemid 44549984)
5. Law M,Young R,Babb J, et al. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. Am J Neuroradiol 2007;28:761-6
6. Young R, Babb J, Law M, et al. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. J Magn Reson Imaging 2007;26:1053-63 (Pubitemid 47548167)
7. Emblem KE, Nedregaard B, Nome T, et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008;247:808-17
8. Jenkinson MD, Smith TS, Joyce KA, et al. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours. Neuroradiology 2006;48:703-13 (Pubitemid 44490047)
9. Zhang H, Rodiger LA, Shen T, et al. Preoperative subtyping of meningiomas by perfusion MR imaging. Neuroradiology 2008;50:835-40
10. Carvalho PA, Schwartz RB, Alexander E 3rd, et al. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 1992;77:565-70
11. Arbab AS, Aoki S, Toyama K, et al. Brain perfusion measured by flow-sensitive alternating inversion recovery (FAIR) and dynamic susceptibility contrast-enhanced magnetic resonance imaging: comparison with nuclear medicine technique. Eur Radiol 2001;11:635-41 (Pubitemid 32755503)
12. Jarnum H, Steffensen EG, Knutsson L, et al. Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging. Neuroradiology 2010;52:307-17
13. Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-25 (Pubitemid 26376710)
14. Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-65 (Pubitemid 20248610)
15. Wu O, Ostergaard L, Sorensen AG. Technical aspects of perfusion-weighted imaging. Neuroimaging Clin N Am 2005;15:623-37, xi (Pubitemid 41796943)
16. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. Am J Neuroradiol 2006;27:859-67 (Pubitemid 44897737)
17. Cha S, Tihan T, Crawford F, et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. Am J Neuroradiol 2005;26:266-73 (Pubitemid 43073303)
18. Hakyemez B, Erdogan C, Ercan I, et al. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005;60:493-502 (Pubitemid 40353027)
19. Fayed N, Davila J, Medrano J, et al. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Eur J Radiol 2008;67:427-33
20. Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classification of the Central Nervous System. 4th edn. Lyon: International Agency for Research on Cancer (IARC), 2007
21. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18 (Pubitemid 43261975)
22. Naumov GN, Akslen LA, Folkman J. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 2006;5:1779-87 (Pubitemid 44435320)
23. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003;3:643-51 (Pubitemid 37236406)
24. Cho SK, Na DG, Ryoo JW, et al. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002; 3:171-9
25. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am J Roentgenol 2002;179:783-9 (Pubitemid 34919600)
26. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrastenhanced T2*-weighted MR imaging. Radiology 1999;211:791-8 (Pubitemid 29249482)
27. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51
28. Senturk S, Oguz KK, Cila A. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner. Diagn Interv Radiol 2009;15:3-12
29. Emblem KE, Scheie D, Due-Tonnessen P, et al. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. Am J Neuroradiol 2008;29:1664-70